Victims of the eugenics law
By The Japan Times,
The Japan Times Editorial
| 02. 03. 2018
A damages lawsuit filed by a woman forcibly sterilized under the now-defunct Eugenic Protection Law should prompt the government to quickly review what happened to the thousands of people who were subjected to such operations, clarify its responsibility for their plight and acknowledge where it erred under the policy. It should then consider remedial steps to those whose rights were infringed through the forced sterilization.
The suit — the first of its kind seeking state redress concerning the 1948 law — was filed Tuesday by a woman in her 60s from Miyagi Prefecture, who charges that the government committed a serious violation of her human rights by making it impossible for her to give birth to and raise children. On the basis of diagnosis by a local hospital in 1972 — when the woman was 15 — that she was suffering from serious hereditary mental retardation, the prefectural eugenic protection review board determined that she had to undergo sterilization. The surgery was carried out with no explanation given by the doctor to her. Afterward, the woman complained regularly of stomach...
Related Articles
By Vittoria Vardanega, SWI swissinfo.ch | 02.13.2026
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents. Stories of “mass donors” have captured public attention, most recently through the Netflix documentary series, The Man with 1,000 Kids...
By Jonathan D. Moreno, Hastings Center Bioethics Forum | 02.09.2026
When I began to write a book about bioethics and the rules-based international order, the idea that the world was facing the greatest geopolitical change since World War II was uncontroversial for those who were paying attention to such esoterica...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...